Alteration in protein expression in PC-3 cells treated with SB715992 and analyzed by Western Blot analysis
Taken from "Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line"
BMC Cancer 2006;6():22-22.
Published online 24 Jan 2006
Copyright © 2006 Davis et al; licensee BioMed Central Ltd.PC-3 cells were treated with 10 nM of SB715992 (p27/β-actin; p15/β-actin; IL-11/β-actin; EGFR/β-actin;).